Clinical Trial Update: Lurbinectedin + Doxorubicin In Leiomyosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating lurbinectedin in combination with doxorubicin for advanced or metastatic soft-tissue sarcoma, including leiomyosarcoma; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Lurbinectedin (lurbinectedin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING